Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 13NIH 5INDUSTRY 3FED 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 9Other hematologic neoplasm 8Sarcoma 5Plasma cell 2Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Classical hematology 1

Conditions

Stomach Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Carcinoma, Ovarian Epithelial 1Brain Neoplasms 1Astrocytoma 1

Interventions

Cisplatin 63Paclitaxel 56Carboplatin 38Taxes 24Radiotherapy 21Gemcitabine 16Brachytherapy 15Filgrastim 14Doxorubicin 13Topotecan 12Platinum 121,2-diaminocyclohexaneplatinum II citrate 12Docetaxel 11Radiation 7Granulocyte Colony-Stimulating Factor 7Chemotherapy, Adjuvant 7pegfilgrastim 6Surgical Procedures, Operative 6Radiotherapy, Intensity-Modulated 6Polymerase Chain Reaction 6Ifosfamide 6Etoposide 6Watchful Waiting 5Radiotherapy, Conformal 5Pemetrexed 5Gene Expression Profiling 5Fluorouracil 5Celecoxib 5Amifostine 5Observation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × sargramostim × Gynecologic × Clear all
NCT00023634 2015-03-06

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

SWOG Cancer Research Network

Phase 1 Terminated
14 enrolled
CNSGastrointestinalGenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Astrocytoma, Brain Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡